- IMVT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Immunovant (IMVT) 8-K20 Dec 23Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ DiseaseFinancial data
Company Profile